Across TCGA pan-cancer cohorts, TET1P1 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of TET1P1’s most consistent transcriptional readouts.
The strongest signal is observed in lung adenocarcinoma (LUAD), where TET1P1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types TET1P1 is over-expressed in tumor.
LUAD and KIRC are the cancer types where TET1P1 tumor–normal differential expression is most reproducible.